Anthracycline-induced cardiomyopathy: secrets and lies

Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience

(2017) Alessandra Fornaro et al.   EUROPEAN JOURNAL OF HEART FAILURE

Cardio-Oncology

(2016) Carrie G. Lenneman et al.   CIRCULATION RESEARCH

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines

(2016) Jose Luis Zamorano et al.   EUROPEAN JOURNAL OF HEART FAILURE

Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy

(2015) D. Cardinale et al.   CIRCULATION

Prevention of Anthracycline-Induced Cardiotoxicity

(2014) Pimprapa Vejpongsa et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cancer Survivors in the United States: Prevalence across the Survivorship Trajectory and Implications for Care

(2013) J. S. de Moor et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Insights Into Onco-Cardiology

(2013) Dimitrios Farmakis et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Abstract LB-339: Cause of death in cancer survivors

(2012) Y. Ning et al.   CANCER RESEARCH

Cancer drugs and the heart: importance and management

(2012) T. M. Suter et al.   EUROPEAN HEART JOURNAL

Anthracycline-Induced Cardiomyopathy

(2010) Daniela Cardinale et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY